Rifampicin News and Research

RSS
LSTM scientists describe new approach to screening potential TB treatments

LSTM scientists describe new approach to screening potential TB treatments

Report: Global increase in drug-resistant TB threatens to ruin efforts to eradicate the disease

Report: Global increase in drug-resistant TB threatens to ruin efforts to eradicate the disease

New study proves that 'super-boosting' approach may help treat children co-infected with TB and HIV

New study proves that 'super-boosting' approach may help treat children co-infected with TB and HIV

New ‘release and kill’ strategy may shorten treatment periods for patients with tuberculosis

New ‘release and kill’ strategy may shorten treatment periods for patients with tuberculosis

Detailed analysis of bacterial proteins offers path for new drugs to curb tuberculosis

Detailed analysis of bacterial proteins offers path for new drugs to curb tuberculosis

Scientists identify key 'survival gene' that reduces mutation rates in mycobacteria

Scientists identify key 'survival gene' that reduces mutation rates in mycobacteria

International travellers may spread antimicrobial-resistant bacteria in their home countries, study reveals

International travellers may spread antimicrobial-resistant bacteria in their home countries, study reveals

Virginia Tech scientists solve structure of enzyme that deactivates important antibiotic

Virginia Tech scientists solve structure of enzyme that deactivates important antibiotic

MIP vaccine could reduce new leprosy cases in India by 60%

MIP vaccine could reduce new leprosy cases in India by 60%

Study provides insight into why individual mycobacteria respond differently to antibiotics

Study provides insight into why individual mycobacteria respond differently to antibiotics

New ultra-fast molecular method can help detect mycobacterial pathogens in the lungs

New ultra-fast molecular method can help detect mycobacterial pathogens in the lungs

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Novel rapid diagnostic test and shorter treatment with better outcomes may benefit MDR-TB patients

Novel rapid diagnostic test and shorter treatment with better outcomes may benefit MDR-TB patients

Health officials to attend International Summit on Tuberculosis and Diabetes in Bali, Indonesia

Health officials to attend International Summit on Tuberculosis and Diabetes in Bali, Indonesia

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn's Akynzeo for CINV prevention receives EC approval

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

STA, Helsinn announce approval of AKYNZEO for prevention of chemotherapy-induced CINV

STA, Helsinn announce approval of AKYNZEO for prevention of chemotherapy-induced CINV